Clinical trials recruiting in Goyang-si Gyeonggi-do, South Korea
3
Recruiting trials
12
Conditions
Phase breakdown
Phase 1 1Phase 3 2
Conditions recruiting in Goyang-si Gyeonggi-do, South Korea
Recruiting trials in Goyang-si Gyeonggi-do, South Korea
- A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)
- A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
- A Study of LY4170156 in Participants With Selected Advanced Solid Tumors
Common questions
How many clinical trials are recruiting in Goyang-si Gyeonggi-do, South Korea?
3 recruiting trials have at least one study site in Goyang-si Gyeonggi-do, South Korea.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.